Clinical Trial Update: Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intensification of entecavir for persistent HBV viremia in people with HIV-HBV infection; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV Infections, Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2013-05-16